In 2024, the U.S. Drug Enforcement Administration (DEA) indicated which they intend to reclassify cannabis as being a Agenda III drug. This rescheduling will understand that cannabis has legitimate medical uses and may help open up the door to study on other possible therapy makes use of.The workforce at Medterra is additionally top-of-the-pack In